Bausch Health Company Insiders

BHC Stock  USD 7.16  0.03  0.42%   
Bausch Health employs about 20.7 K people. The company is managed by 39 executives with a total tenure of roughly 162 years, averaging almost 4.0 years of service per executive, having 530.77 employees per reported executive. Evaluation of Bausch Health's management performance can provide insight into the firm performance.
William Humphries  Chairman
Executive Vice President Company Group Chairman, Dermatology
Joseph Papa  Chairman
Chairman of the Board, Chief Executive Officer
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Bausch Health's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Bausch Health's future performance. Based on our forecasts, it is anticipated that Bausch will maintain a workforce of about 20700 employees by April 2025.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Bausch Health Management Team Effectiveness

The company has Return on Asset of 0.0433 % which means that on every $100 spent on assets, it made $0.0433 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (23.0454) %, meaning that it generated no profit with money invested by stockholders. Bausch Health's management efficiency ratios could be used to measure how well Bausch Health manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Capital Employed is expected to grow to 0.10, whereas Return On Tangible Assets are projected to grow to (0). At present, Bausch Health's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Intangible Assets is expected to grow to about 5.8 B, whereas Total Assets are forecasted to decline to about 15.4 B.
As of March 24, 2025, Common Stock Shares Outstanding is expected to decline to about 251.3 M. In addition to that, Net Loss is expected to decline to about (212.6 M)

Bausch Health Workforce Comparison

Bausch Health Companies is rated fourth in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 176,352. Bausch Health retains roughly 20,700 in number of employees claiming about 12% of equities under Health Care industry.

Bausch Health Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Bausch Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Bausch Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Bausch Health insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-12-01
1.5
3
2
 12,715 
 2,132 
2024-09-01
1.5
6
4
 505,004 
 83,372 
2024-06-01
12.0
12
1
 332,945 
 1,930 
2024-03-01
0.5385
7
13
 718,594 
 150,726 
2023-12-01
1.0
4
4
 16,676 
 2,288 
2023-09-01
0.8
4
5
 16,269 
 120,063 
2023-06-01
13.0
13
1
 279,562 
 1,929 
2023-03-01
0.5714
12
21
 1,033,324 
 59,123 
2022-12-01
3.0
6
2
 30,883 
 2,025 
2022-09-01
11.0
11
1
 734,670 
 15,389 
2022-06-01
1.7647
30
17
 929,265 
 763,516 
2022-03-01
0.5227
23
44
 1,460,990 
 558,448 
2021-12-01
4.5
9
2
 67,447 
 3,744 
2021-09-01
3.0
12
4
 238,491 
 14,854 
2021-06-01
2.0
22
11
 374,876 
 317,105 
2021-03-01
1.619
34
21
 1,377,114 
 807,889 
2020-12-01
1.0
7
7
 42,000 
 76,832 
2020-09-01
0.8333
5
6
 35,127 
 21,892 
2020-06-01
3.375
27
8
 6,064,443 
 1,172,387 
2020-03-01
1.1667
35
30
 1,320,046 
 254,338 
2019-12-01
4.0
4
1
 4,281 
 3,337 
2019-09-01
1.0
8
8
 118,516 
 65,682 
2019-06-01
2.0
14
7
 111,408 
 129,154 
2019-03-01
1.6923
22
13
 944,388 
 62,273 
2018-12-01
2.3333
7
3
 63,817 
 19,946 
2018-09-01
0.5294
9
17
 209,965 
 234,592 
2018-06-01
6.0
24
4
 283,978 
 105,400 
2018-03-01
3.8333
23
6
 8,656,748 
 7,089,655 
2017-12-01
6.0
6
1
 360,349 
 344,216 
2017-09-01
1.5
6
4
 18,836 
 1,003,273 
2017-06-01
2.3333
14
6
 254,703 
 20,408 
2017-03-01
20.0
20
1
 645,182 
 0.00 
2016-12-01
0.8333
5
6
 9,130,508 
 3,524,643 
2016-09-01
1.1667
7
6
 183,948 
 24,582 
2016-06-01
2.4
24
10
 12,778,244 
 18,240,000 
2016-03-01
0.1429
1
7
 1,096 
 57,408 
2015-12-01
1.5
9
6
 14,227 
 1,314,057 
2015-06-01
1.0357
29
28
 424,183 
 4,843,370 
2015-03-01
0.9167
11
12
 712,680 
 310,412 
2014-12-01
1.3636
15
11
 681,876 
 141,674 
2014-09-01
1.0
4
4
 18,810 
 30,119 

Bausch Health Notable Stakeholders

A Bausch Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Bausch Health often face trade-offs trying to please all of them. Bausch Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Bausch Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
William HumphriesExecutive Vice President Company Group Chairman, DermatologyProfile
Joseph PapaChairman of the Board, Chief Executive OfficerProfile
Thomas AppioExecutive Vice President Company Group Chairman, InternationalProfile
Paul HerendeenChief Financial Officer, Executive Vice PresidentProfile
Joseph GordonPresident and Co-Head Bausch + Lomb/InternationalProfile
Christina AckermannExecutive Vice President, General Counsel and Head of Commercial OperationsProfile
Mirza DautbegovicExecutive COOProfile
Sarah KavanaghIndependent DirectorProfile
Richard SchutterIndependent DirectorProfile
Amy WechslerIndependent DirectorProfile
Robert PowerIndependent DirectorProfile
Argeris KarabelasIndependent DirectorProfile
Thomas RossLead Independent DirectorProfile
Andrew EschenbachIndependent DirectorProfile
John PaulsonIndependent DirectorProfile
Russel RobertsonIndependent DirectorProfile
John BarresiController, VPProfile
Garen SarafianVP RelationsProfile
MSc MDChief VPProfile
D HaleIndependent DirectorProfile
Jeff HartnessCommercial AccessProfile
Arthur ShannonIR Contact OfficerProfile
Tage MDChief RDProfile
Robert ButzVP AffairsProfile
Brett IcahnIndependent DirectorProfile
Seana CarsonExecutive CounselProfile
Josh CoyleSenior SalixProfile
Graham JacksonSenior OfficerProfile
Sam WillSenior Vice President - Finance, Chief Accounting Officer, ControllerProfile
Thomas VadakethEx CFOProfile
Kathleen FitzpatrickExecutive OfficerProfile
Jiny MBASenior MedicalProfile
William WoodfieldSenior TreasurerProfile
Donald PearlSenior DermatologicsProfile
JeanJacques CharhonChief OfficerProfile
Aimee LenarExecutive PharmaProfile
Steven MillerIndependent DirectorProfile
Robert SpurrPresident - SalixProfile
Cees HeimanSenior CanadaProfile

About Bausch Health Management Performance

The success or failure of an entity such as Bausch Health Companies often depends on how effective the management is. Bausch Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Bausch management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Bausch management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Capital Employed 0.08  0.10 
Return On Equity 0.04  0.03 
Please note, the presentation of Bausch Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Bausch Health's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Bausch Health's management manipulating its earnings.

Bausch Health Workforce Analysis

Traditionally, organizations such as Bausch Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Bausch Health within its industry.

Bausch Health Manpower Efficiency

Return on Bausch Health Manpower

Revenue Per Employee459.8K
Revenue Per Executive244.1M
Net Loss Per Employee3.5K
Net Loss Per Executive1.8M

Complementary Tools for Bausch Stock analysis

When running Bausch Health's price analysis, check to measure Bausch Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bausch Health is operating at the current time. Most of Bausch Health's value examination focuses on studying past and present price action to predict the probability of Bausch Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bausch Health's price. Additionally, you may evaluate how the addition of Bausch Health to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities